Kemet Corp. (KEM) Misses Q4 EPS by 6c
Tweet
Share
E-mailGet Alerts KEM Hot Sheet
Price: $27.58 --0%
Financial Fact:
Research and development: 7.12M
Today's EPS Names:
VAXX, EGRX, AFIB, More
Financial Fact:
Research and development: 7.12M
Today's EPS Names:
VAXX, EGRX, AFIB, More
Join SI Premium – FREE
Kemet Corp. (NYSE: KEM) reported Q4 EPS of ($0.04), $0.06 worse than the analyst estimate of $0.02. Revenue for the quarter came in at $212.9 million versus the consensus estimate of $215.6 million.
For earnings history and earnings-related data on Kemet Corp. (KEM) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- JPMorgan Upgrades Aviva Plc (AV/:LN) (AIVAF) to Overweight
- Global Net Lease completes Modiv Industrial acquisition for $535M
- Cytokinetics (CYTK) PT Raised to $110 at Barclays
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
